BAQSIMI
Live / Registered — Registered (as of 10 Nov 2020)
What this means for you
Registered since 10 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87828329
- Registration number
- 6195596
- Mark type
- Design + words
- Filed
- 09 Mar 2018
- Published for opposition
- 17 Jul 2018
- Registered
- 10 Nov 2020
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction
Owner
- AMPHASTAR PHARMACEUTICALS, INC., RANCHO CUCAMONGA, CA, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 10 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Aug 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2020 — USE AMENDMENT FILED
- 30 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 04 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED